Letermovir and Hypertension aggravated - a phase IV clinical study of FDA data

Summary:

Hypertension aggravated is reported as a side effect among people who take Letermovir (letermovir), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Posaconazole, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Hypertension aggravated when taking Letermovir. It is created by eHealthMe based on reports of 949 people who have side effects when taking Letermovir from the FDA, and is updated regularly.

What is Letermovir?

Letermovir has active ingredients of letermovir. eHealthMe is studying from 949 Letermovir users. Check the latest studies of Letermovir.

What is Hypertension aggravated?

Hypertension aggravated (high blood pressure) is found to be associated with 2,695 drugs and 842 conditions by eHealthMe. Check the latest studies of Hypertension aggravated.

On Jul, 15, 2026

949 people reported to have side effects when taking Letermovir.
Among them, 14 people (1.48%) have Hypertension aggravated.

Could Letermovir cause Hypertension aggravated?

Among these 14 people:

How long have people been on Letermovir when they have Hypertension aggravated? *

What is the gender of people who have Hypertension aggravated when taking Letermovir? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Hypertension aggravated when taking Letermovir? *

What are other drugs people take besides Letermovir? *

What are other side effects people have besides Hypertension aggravated? *

Transaminases Increased: 8 people, 57.14%
Joint Pain: 7 people, 50.00%
Rashes (redness): 7 people, 50.00%
Fatigue (feeling of tiredness): 7 people, 50.00%
Fever: 5 people, 35.71%
White Blood Cell Count Decreased: 4 people, 28.57%
Dyspnea (difficult or laboured breathing): 4 people, 28.57%
Leukopenia (less number of white blood cells in blood): 4 people, 28.57%
Heart Rate Increased: 4 people, 28.57%
Haematocrit Decreased: 4 people, 28.57%

What are the existing conditions these people have? *

Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 28.57%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 28.57%
Immunodeficiency Disorders: 3 people, 21.43%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 21.43%
Type 2 Diabetes: 1 person, 7.14%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 7.14%
Muscle Aches (muscle pain): 1 person, 7.14%
Insomnia (sleeplessness): 1 person, 7.14%
Dyslipidaemia (abnormal amount of lipids): 1 person, 7.14%
Diabetes: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Letermovir and have Hypertension aggravated?

- Check whether Hypertension aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Letermovir:

Letermovir (949 reports)

Browse all side effects of Letermovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertension aggravated:

Hypertension aggravated (2,696 drugs)

Browse all the conditions that are associated with Hypertension aggravated:

Hypertension aggravated (842 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on letermovir (the active ingredients of Letermovir) and Letermovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.